Stay up-to-date with advances in chronic kidney disease (CKD)! Join our esteemed Chief of Nephrology at Kashlak Memorial Hospital, Dr. Joel Topf, as he leads us through the latest on SGLT2 inhibitors, finerenone, potassium binders, and treatment of CKD-associated metabolic acidosis.

Claim free CME for this episode at curbsiders.vcuhealth.org!

Episodes | Subscribe | Spotify | YouTube | Mailing List | askcurbsiders@gmail.com | Swag! | Free CME!

Show Segments

Intro, disclaimer, guest bio
Case from Kashlak
SGLT2i: when to initiate
SGLT2i: adverse effects
Finerenone
Potassium binders
Treatment of CKD-associated metabolic acidosis
Outro

Credits

Writer, Producer, Show Notes, Infographics, and Cover Art: Malini Gandhi
Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
Reviewer: Leah Witt MD
Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
Technical Production: PodPaste
Guest: Dr. Joel Topf MD

Sponsor: Better Help
Visit betterhelp.com/curb today to get 10% off your first month.

Sponsor: Birch Living
Birch is giving 20% off all mattresses and 2 free eco-rest pillows at birchliving.com/curb.

Sponsor: PanaceaFinancial

Visit panaceafinancial.com to open a free account.

Full transcript available HERE

#384 Updates in Chronic Kidney Disease with Dr. Joel Topf

The Curbsiders Internal Medicine Podcast